ClinicalTrials.Veeva

Menu
Unison Clinical Trials | Sherman Oaks, CA logo

Unison Clinical Trials | Sherman Oaks, CA

Research site

Site insights

Top conditions

Top treatments

SCD-044
TAK-279
ABP 501
Ixekizumab
Differin
MD-7246
AUR101
BMS-986165
ABP 654
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Linda Almaraz

Verified by this site

Active trials

5 of 20 total trials

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Enrolling
Plaque Psoriasis
Drug: TAK-279

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Enrolling
Psoriasis
Severe Psoriasis
Drug: Open-Label ESK-001
Drug: Blinded ESK-001

The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis a...

Active, not recruiting
Atopic Dermatitis
Psoriasis
Biological: XmAb27564
Biological: Placebo

The purpose of this study is to determine the efficacy and safety of a monoclonal antibody, OpSCF, in the treatment of adults with moderate to severe...

Active, not recruiting
Atopic Dermatitis
Biological: Placebo
Biological: OpSCF

This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.

Active, not recruiting
Moderate to Severe Plaque Psoriasis
Drug: Placebo
Drug: SCD-044_Dose 3

Trial sponsors

Amgen logo
Exact Sciences Corporation logo
Sun Pharma logo
AbbVie logo
A
A
A
Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
Ironwood Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems